A role for histone deacetylase HDAC1 in modulating the transcriptional activity of MyoD: Inhibition of the myogenic program

EMBO Journal

Volumn 20, Issue 7, 2001, Pages 1739-1753

  Mal, Asoke ^a   Sturniolo, Michael ^a   Schiltz, R Louis ^b   Ghosh, Mrinal K ^a   Harter, Marian L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

HDAC1; MyoD; Myogenic conversion; Skeletal muscle cells

Indexed keywords

HISTONE DEACETYLASE; MYOD PROTEIN; PROTEIN P21;

ACETYLATION; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE REPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; MOLECULAR INTERACTION; MOUSE; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SKELETAL MUSCLE;

ACETYLATION; ACETYLTRANSFERASES; ANIMALS; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL LINE; CELL LINE, TRANSFORMED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; HISTONE ACETYLTRANSFERASES; HISTONE DEACETYLASES; HUMANS; JURKAT CELLS; MICE; MUSCLE, SKELETAL; MYOD PROTEIN; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

ANIMALIA;

EID: 0035794552     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/20.7.1739     Document Type: Article

References (77)

1. Myogenin expression, cell cycle withdrawal and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis
2. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells
3. Muscle differentiation: More complexity to the network of myogenic regulators
4. Identification of mouse histone deacetylase 1 as a gowth factor-inducible gene
5. The protein Id: A negative regulator of helix-loop-helix DNA binding proteins
6. Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection
7. Regulation of activity of the transcription factor GATA-1 by acetylation
8. Retinoblastoma protein recruits histone deacetylase to repress transcription
9. The many HATs of transcription coactivators
10. Expression of a single transfected cDNA converts fibroblasts to myoblasts
11. Histone deacetylase 1 can repress transcription by binding to Sp1
12. Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation
13. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins
14. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain
15. Inhibition of myogenesis by multiple cyclin-cdk complexes
16. MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation
17. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD
18. Cdk inhibitors in development and cancer
19. A role for histone deacetylase activity in HDAC1-mediated transcriptional repression
20. Use of a conditional MyoD transcription factor in studies of MyoD transactivation and muscle determination
21. Functional receptors for transforming growth factor-β are retained by biochemically differentiated C2 myocytes in growth factor-deficient medium containing EGTA but down-regulated during terminal differentiation
22. Micrococcal nuclease digestion of nuclei reveals extended nucleosome ladders having anomalous DNA lengths for chromatin assembled on non-replicating plasmids in transfected cells
23. Sodium butyrate inhibits myogenesis by interfering with the transcriptional activation function of MyoD and myogenin
24. Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes
25. cdk1- and cdk2-mediated phosphorylation of MyoD Ser200 in growing C2 myoblasts: Role in modulating MyoD half-life and myogenic activity
26. Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes
27. Transcription factor-specific requirements for coactivators and their acetyltransferase functions
28. Effects of sodium butyrate, a new pharmacological agent, on cells in culture
29. MyoD is a sequence-specific DNA binding protein requiring a region of myc homology to bind to the muscle creatine kinase enhancer
30. Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal
31. The basic helix-loop-helix transcription factor Mist1 functions as a transcriptional repressor of myoD
32. p53 sites are acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage
33. Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases
34. Rb interacts with histone deacetylase to repress transcription
35. Crystal structure of MyoD bHLH domain-DNA complex: Perspectives on DNA recognition and implications for transcriptional activation
36. Retinoblastoma protein represses transcription by recruiting a histone deacetylase
37. Interdependence between muscle differentiation and cell-cycle control
38. Kip1 in TGF-β treated cells
39. p21 and retinoblastoma protein control the absence of DNA replication in terminally differentiated muscle cells
40. Regulation of E2F1 activity by acetylation
41. HDAC4 deacetylase associates with and represses the MEF2 transcription factor
42. Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a
43. MEF2: A transcriptional target for signaling pathways controlling skeletal muscle growth and differentiation
44. HLH forced dimers: Tethering MyoD to E47 generates a dominant positive myogenic factor insulated from negative regulation by Id
45. Skeletal muscle cultures
46. Histone deacetylases: Silencers for hire
47. pRb is required for MEF2-dependent gene expression as well as cell-cycle arrest during skeletal muscle differentiation
48. The transcriptional coactivators p300 and CBP are histone acetytransferases
49. Interplay between proliferation and differentiation within the myogenic lineage
50. Inactivation of MyoD-mediated expression of p21 in tumor cell lines
51. Cip1 in muscle and other terminally differentiating cells
52. CBP/p300 activates MyoD by acetylation
53. p300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription
54. Differential roles of p300 and PCAF acetyltransferases in muscle differentiation
55. Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators
56. Kip2 stabilizes the MyoD protein by inhibiting cyclin E-cdk2 kinase activity in growing myoblasts
57. DNA damage activates p53 through a phosphorylation-acetylation cascade
58. Molecular mechanisms of myogenic coactivation by p300: Direct interaction with the activation domain of MyoD and with the MADS box of MEF2C
59. Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program
60. Butyrate stimulates cyclin D and p21 and inhibits cyclin-dependent kinase 2 expression in HT-29 colonic epithelial cells
61. Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: Induction of cyclin D3 and p21 expression
62. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase
63. Cyclin-mediated inhibition of muscle gene expression via a mechanism that is independent of pRB hyperphosphorylation
64. Phosphorylation of nuclear MyoD is required for its rapid degradation
65. Inhibition of myogenic bHLH and MEF2 transcription factors by the bHLH protein twist
66. 5-bromo-2′-deoxyuridine blocks myogenesis by extinguishing expression of MyoD1
67. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p
68. 1-phase degradation of MyoD in muscle cells
69. Inhibition of retinoblastoma protein phosphorylation by myogenesis-induced changes in the subunit composition of the cyclin-dependent kinase 4 complex
70. The MyoD family and myogenesis: Redundancy, networks and thresholds
71. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle
72. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A
73. Human p300 protein is a coactivator for the transcription factor MyoD
74. Coupling of the cell cycle and myogenesis through the cyclin D1-dependent interaction of MyoD with cdk4
75. 1 cdk kinase activity by MyoD promotes myoblast cell cycle withdrawal and terminal differentiation
76. KIP2 control muscle differentiation at the myogenin step
77. Acetylation and modulation of erythroid Krüppel-like factor (EKLF) activity by interaction with histone acetyltransferases